These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37614548)

  • 41. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
    Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients.
    Romiti GF; Pastori D; Rivera-Caravaca JM; Ding WY; Gue YX; Menichelli D; Gumprecht J; Kozieł M; Yang PS; Guo Y; Lip GYH; Proietti M
    Thromb Haemost; 2022 Mar; 122(3):406-414. PubMed ID: 34020488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.
    Chao TF; Joung B; Takahashi Y; Lim TW; Choi EK; Chan YH; Guo Y; Sriratanasathavorn C; Oh S; Okumura K; Lip GYH
    J Arrhythm; 2021 Dec; 37(6):1389-1426. PubMed ID: 34887945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adherence to Atrial Fibrillation Better Care (ABC) Pathway Management of Chinese Community Elderly Patients with Atrial Fibrillation: A Cross-Sectional Study.
    Zhang X; Huang J; Weng F; Wen Y; Wang X; Jiang J; Xue Y; Li K
    Patient Prefer Adherence; 2023; 17():1813-1823. PubMed ID: 37520064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relation of changes in ABC pathway compliance status to clinical outcomes in patients with atrial fibrillation: A report from the COOL-AF registry.
    Krittayaphong R; Chichareon P; Methavigul K; Treewaree S; Lip GYH
    Eur Heart J Qual Care Clin Outcomes; 2024 May; ():. PubMed ID: 38794883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].
    Liu XB; Jia ZX; Xia SJ; He L; Lu SX; Guo XY; Li SN; Liu N; Jiang CX; Sang CH; Tang RB; Long DY; Yu RH; Bai R; Wu JH; Du X; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):735-739. PubMed ID: 32957755
    [No Abstract]   [Full Text] [Related]  

  • 53. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists.
    Roldán V; Martínez-Montesinos L; López-Gálvez R; García-Tomás L; Lip GYH; Rivera-Caravaca JM; Marín F
    J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Competitive interaction between chronic obstructive pulmonary disease and CHA
    Perticone M; Sciacqua A; Tripepi G; Miceli S; Corrao S; Sesti G; Perticone F
    Int J Cardiol; 2018 Mar; 255():74-79. PubMed ID: 29174184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry.
    Proietti M; Vitolo M; Harrison SL; Lane DA; Fauchier L; Marin F; Nabauer M; Potpara TS; Dan GA; Boriani G; Lip GYH;
    Clin Res Cardiol; 2022 Jan; 111(1):70-84. PubMed ID: 34448931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.
    Bucci T; Shantsila A; Romiti GF; Teo WS; Park HW; Shimizu W; Mei DA; Tse HF; Proietti M; Chao TF; Lip GYH;
    Sci Rep; 2023 Oct; 13(1):18375. PubMed ID: 37884587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry.
    Piccini JP; Simon DN; Steinberg BA; Thomas L; Allen LA; Fonarow GC; Gersh B; Hylek E; Kowey PR; Reiffel JA; Naccarelli GV; Chan PS; Spertus JA; Peterson ED;
    JAMA Cardiol; 2016 Jun; 1(3):282-91. PubMed ID: 27438106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
    Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
    Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mobile health-technology integrated care in secondary prevention atrial fibrillation patients: a post-hoc analysis from the mAFA-II randomized clinical trial.
    Guo Y; Romiti GF; Sagris D; Proietti M; Bonini N; Zhang H; Lip GYH;
    Intern Emerg Med; 2023 Jun; 18(4):1041-1048. PubMed ID: 36929347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.